Interstitial Nephritis in a Patient with Inflammatory Bowel Disease

الملخص EN

Tubulointerstitial nephritis in patients with inflammatory bowel disease has been linked to the use of 5-ASA derivatives.

Various aspects of this theory have been challenged with a potential role for the underlying autoimmune disorder.

Steroids are the mainstay of treatment and mycophenolate mofetil might be an effective alternative.

We report a patient who responded well to mycophenolate despite continuing mesalamine, the suspected offending agent.